Disclosure Considerations for UK and EU Public Companies in the Context of the COVID-19 Pandemic
May 4, 2020
Public companies in the EU and the UK will be required to think carefully about their disclosure obligations as the COVID-19 pandemic continues.
Many public companies have withdrawn or amended published earnings guidance as a result of the crisis, while various regulators have permitted delays to issuers’ publication of annual and quarterly financial reports. Issuers should be conscious of their ongoing disclosure obligations under the EU Market Abuse Regulation (“MAR”),both in the context of their ordinary course reporting to the market and in their offering documentation.
Click here for the full alert memorandum.